Kyle Wilks
Net worth: 12 181 $ as of 30/05/2024
Profile
Kyle Wilks worked as an Executive Director at Montgomery Pacific Group LLC.
He was a Senior Manager at Baxter International, Inc. from 2009 to 2015 and at Shire Plc from 2015 to 2019.
He also served as an Independent Non-Executive Director at Evome Medical Technologies, Inc. from 2020 to 2024.
Prior to his career in the private sector, he was a Professor at the United States Naval Academy.
Mr. Wilks received his undergraduate degree from the United States Naval Academy.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
06/07/2023 | 114,914 ( 0.20% ) | 12 181 $ | 30/05/2024 |
Former positions of Kyle Wilks
Companies | Position | End |
---|---|---|
EVOME MEDICAL TECHNOLOGIES INC. | Director/Board Member | 09/01/2024 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 31/12/2018 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 31/12/2014 |
United States Naval Academy | Corporate Officer/Principal | - |
Montgomery Pacific Group LLC
Montgomery Pacific Group LLC Investment Banks/BrokersFinance Montgomery Pacific Group LLC is an investment bank. The private company is based in Bethesda, MD. | Director/Board Member | - |
Training of Kyle Wilks
United States Naval Academy | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
EVOME MEDICAL TECHNOLOGIES INC. | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
Private companies | 2 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Montgomery Pacific Group LLC
Montgomery Pacific Group LLC Investment Banks/BrokersFinance Montgomery Pacific Group LLC is an investment bank. The private company is based in Bethesda, MD. | Finance |
- Stock Market
- Insiders
- Kyle Wilks